Skip to main content
. Author manuscript; available in PMC: 2017 May 23.
Published in final edited form as: Receptors Clin Investig. 2016 May 23;3(2):e1310.

Figure 4. vPARP protects against cell death.

Figure 4

Human bronchial smooth muscle cells were transfected with control siRNA or siRNA to knockdown vPARP (Santa Cruz). (A) The cell number was determined by counting on a hemocytometer. (B & C) Cell lysates were subjected to immunoblotting to monitor the expression of cleaved caspase-3 (Cell Signaling Technology, Danvers, MA, USA) and vPARP (Santa Cruz). Bar graphs represent means ± SEM (n = 4). * denotes values significantly different from control at P<0.05.